Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

Phase 1 Recruiting 36 enrolled IlDong Pharmaceutical Co Ltd YUNOVIA CO.,LTD. · collab

RandomizedSequentialDouble-blindBasic science

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral doses of ID110521156 in healthy adult subjects.

Timeline

Start: 2024-11-13
Primary completion: 2025-06-19
Completion: 2025-06-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ID110521156	Unknown	—	Oral

Indications

No indication recorded.